Keywords: gsk, relenza, cleared, eu, use, adults, children

GSK's Relenza cleared in EU for use in adults and children

Article | 04 September 2006

Print This

The UK's GlaxoSmithKline says that it has received European regulatory approval for use of its antiviral Relenza (zanamivir for inhalation) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in